-141 C Del/Ins polymorphism of the dopamine receptor 2 gene is associated with schizophrenia in a British population

American Journal of Medical Genetics - Neuropsychiatric Genetics

Volumn 88, Issue 4, 1999, Pages 407-410

  Breen, Gerome ^a,b   Brown, John ^a   Maude, Sophia ^a   Fox, Helen ^a   Collier, David ^c   Li, Tao ^c   Arranz, Maria ^c   Shaw, Duncan ^b   St Clair, David ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

^b UNIVERSITY OF ABERDEEN   (United Kingdom)

^c KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Association; Dopamine; DRD2 gene; Insertion; Linkage Disequilibrium; Schizophrenia

Indexed keywords

DOPAMINE 2 RECEPTOR;

ARTICLE; CONTROLLED STUDY; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SCHIZOPHRENIA; UNITED KINGDOM;

ALLELES; CASE-CONTROL STUDIES; GENOTYPE; GREAT BRITAIN; HUMANS; LINKAGE DISEQUILIBRIUM; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; RECEPTORS, DOPAMINE D2; SCHIZOPHRENIA;

EID: 0033588110     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/(SICI)1096-8628(19990820)88:4<407::AID-AJMG19>3.0.CO;2-3     Document Type: Article

References (23)

1. American Psychiatric Association. 1980. Diagnostic and statistical manual of mental disorders, 3rd ed. American Psychiatric Association, Washington, D.C.
2. American Psychiatric Association. 1994. Diagnostic and statistical manual of mental disorders, 4th ed. American Psychiatric Association, Washington, D.C.
3. Arinami T, Gao M, Hamaguchi H, Toru M. 1997. A functional polymorphism in the promoter region of the dopamine D4 receptor gene is associated with schizophrenia. Human Mol Genet 6:577-582.
4. Arinami T, Itokawa M, Aoki J, Shibuya H, Ookubu Y, Iwawaki A, Ota K, Shimizu H, Hamaguchi H, Toru, M. 1996. Further association study of the dopamine D2 receptor variant S311C in schizophrenia and affective disorders. Am J Med Genet 67:133-138.
5. Arinami T, Itokawa M, Enguchi H, Tagaya H, Yano S, Shimizu H, Hamaguchi H, Toru M. 1994. Association of a dopamine D2 molecular variant with schizophrenia. Lancet 343:703-304.
6. Asherson P, Williams N, Roberts E, McGuffm P, Owen M. 1994. DRD2 Ser311/Cys311 polymorphism in schizophrenia [letter] Lancet 343: 1045.
7. Creese I, Burt DR, Snyder SH. 1976. Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs. Science 192:481-483.
8. Crow TJ. 1997. Current status of linkage for schizophrenia: polygenes of vanishingly small effect or multiple false positives? Am J Med Genet 74:99-103.
9. Ellison G. 1994. Stimulant-induced psychosis, the dopamine theory of schizophrenia, and the habenula. Brain Res Brain Res Rev 19:223-39.
10. Endicott J, Spitzer RL. 1978. A diagnostic review: the Schedule for Affec tive Disorders and Schizophrenia. Archives of General Psychiatry 35: 837-844.
11. Fleiss M. 1981. Statistical methods for rates and proportions, 2nd ed. New York: John Wiley & Sons.
12. Laurent C, Bodeau-Pean S, Campion D, d'Amato T, Jay M, Dollfus S, Thibault F, Petit M, Samolyk D, Martinez M, et al. 1994. No major role for the dopamine D2 receptor Ser→Cys311 mutation in schizophrenia. Psychiatr Genet 4:229-230.
13. Li T, Arranz M, Aitchison KJ, Bryant C, Liu X, Kerwin RW, Murray R, Sham P, Collier DA. 1998. Case-control, haplotype relative risk and transmission disequilibrium analysis of a dopamine D2 receptor functional promoter polymorphism in schizophrenia. Schizophr Res, 32:87-92.
14. McGuffin P, Owen MJ, Farmer AE. 1995. Genetic basis of schizophrenia. Lancet 346:678-682.
15. Nanko S, Hattori M, Dai XY, Fukuda R, Kazamatsuri H. 1994. DRD2 Ser311/Cys311 polymorphism in schizophrenia. Lancet 343:1044.
16. Nothen MM, Wildenauer D, Cichon S, Albus M, Maier W, Minges J, Lichtermann D, Bondy B, Rietschel M, Korner J, et al. 1994. Dopamine D2 receptor molecular variant and schizophrenia Lancet 343:1301-1302.
17. Sasaki T, Macciardi FM, Badri F, Verga M, Meltzer HY, Lieberman J, Howard A, Bean G, Joffe RT, Hudson CJ, Kennedy JL. 1996. No evidence for association of dopamine D2 receptor variant (Ser311/Cys311. with major psychosis. Am J Med Genet 67:415-417.
18. Seeman P, Lee T, Chau-Wong M, Wong, K. 1976. Antipsychotic drug doses and neuroleptic/dopamine receptors. Nature 261:717-719.
19. Seeman P, Guan HC, Van Tol HH. 1993. Dopamine D4 receptors elevated in schizophrenia. Nature 365:441-445.
20. Shaikh S, Collier D, Arranz M, Ball D, Gill M, Kerwin R. 1994. DRD2 Ser311/Cys311 polymorphism in schizophrenia. Lancet 343:1045-1046.
21. Sham P, Curtis D. 1995. An extended transmission/disequilibrium test (TDT) for multi-allele marker loci. Ann Human Genet 59:323-336.
22. Smith M, Wasmuth J, McPherson JD, Wagner C, Grandy D, Civelli O, Potkin S, Litt M. 1989. Cosegregation of an 11q22.3-9p22 translocation with affective disorder: proximity of the dopamine D2 receptor gene relative to the translocation breakpoint. Abstract. Am J Hum Genet 45 (suppl.):A220.
23. Van Rossum JM. 1966. The significance of dopamine-receptor blockade for the mechanism of action of neuroleptic drugs. Arch Int Pharmacodyn Ther 160:492-4.